A critical appraisal of the measurement of serum 'cholesterol efflux capacity' and its use as surrogate marker of risk of cardiovascular disease.

MLA

Anastasius, Malcolm, et al. “A Critical Appraisal of the Measurement of Serum ‘Cholesterol Efflux Capacity’ and Its Use as Surrogate Marker of Risk of Cardiovascular Disease.” Biochimica et Biophysica Acta. Molecular and Cell Biology of Lipids, vol. 1863, no. 10, Oct. 2018, pp. 1257–73. EBSCOhost, https://doi.org/10.1016/j.bbalip.2018.08.002.

APA

Anastasius, M., Luquain-Costaz, C., Kockx, M., Jessup, W., & Kritharides, L. (2018). A critical appraisal of the measurement of serum “cholesterol efflux capacity” and its use as surrogate marker of risk of cardiovascular disease. Biochimica et Biophysica Acta. Molecular and Cell Biology of Lipids, 1863(10), 1257–1273. https://doi.org/10.1016/j.bbalip.2018.08.002

Chicago

Anastasius, Malcolm, Celine Luquain-Costaz, Maaike Kockx, Wendy Jessup, and Leonard Kritharides. 2018. “A Critical Appraisal of the Measurement of Serum ‘Cholesterol Efflux Capacity’ and Its Use as Surrogate Marker of Risk of Cardiovascular Disease.” Biochimica et Biophysica Acta. Molecular and Cell Biology of Lipids 1863 (10): 1257–73. doi:10.1016/j.bbalip.2018.08.002.